Finally, combined with the transcriptomics of peripheral blood cells from multiple AD cohorts, we found that PDHB, SUCLA2, and MDH1 can be used as candidate biomarkers for early diagnosis of AD. This evidence concerns the gene MDH1 and Alzheimer disease.